Sansure Biotech Inc. (688289.SS) SHH
16.22
-0.33(-1.99%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
16.22
-0.33(-1.99%)
Currency In CNY
Address
No. 680, Lusong Road
Changsha, 410205
China
Phone
86 731 8973 6948
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
2006
First IPO Date
August 28, 2020
| Name | Title | Pay | Year Born |
| Lizhong Dai | Chairman of the Board & GM | 0 | 1968 |
| Qiang Huang | Secretary | 0 | 1982 |
| Zhu Peng | Chief Financial Officer, Deputy GM & Director | 0 | 1975 |
| Xialin Yu | Deputy GM & Director | 0 | 1979 |
| Haixiao Wang | Deputy General Manager | 0 | 1978 |
| Kai Liu | Deputy General Manager | 0 | 1977 |
| Zhongping Deng | Deputy General Manager | 0 | 1977 |
| Jia Liu | Deputy GM & Director | 0 | 1982 |
| Jun Zhou | Deputy General Manager | 0 | 1971 |
| Xiaoyan Xiong | Deputy General Manager | 0 | 1983 |
Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.